Biotech

All Articles

Former Seagen chief executive officer reveals brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for an enormous $4...

Ironwood produces additional purpose $1B GI medicine along with new subgroup records

.On the heels of a period 3 succeed that fell short to impress financiers, Ironwood Pharmaceuticals ...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapies right now. The Boston-based biotech is having a ball after authori...

Jade takes exec team along with Chinook vets-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings an...

Septerna goes social with upsized offering of $288M

.Commemorating his firm's upsized initial public offering (IPO), Septerna chief executive officer Je...

AbbVie creates Richter richer, paying for $25M to form breakthrough treaty

.AbbVie has actually returned to the source of its own antipsychotic goliath Vraylar trying to find ...

GenSight gets into ultimate full weeks of cash path as income flow noses out of scope

.GenSight Biologics is full weeks away from losing amount of money. Once again. The biotech merely h...

AZ licenses discarded rare condition medicine to Monopar Rehabs

.Monopar Therapeutics is actually bouncing back a medication from the dump of AstraZeneca's rare dis...

Arcus' brand new HIF-2a data in renal cancer cells hint at possible upper hand over Merck's Welireg, experts claim

.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professio...

Roche bets approximately $1B to expand Dyno genetics therapy distribution pact

.After developing a gene treatment relationship along with Dyno Therapies in 2020, Roche is back for...